Strattera and Hyperventilation - a phase IV clinical study of FDA data

Summary:

Hyperventilation is reported as a side effect among people who take Strattera (atomoxetine hydrochloride), especially for people who are male, 10-19 old, have been taking the drug for < 1 month also take Zoloft, and have Hypothyroidism.

The phase IV clinical study analyzes which people have Hyperventilation when taking Strattera. It is created by eHealthMe based on reports of 27,428 people who have side effects when taking Strattera from the FDA, and is updated regularly.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,323 Strattera users. Check the latest studies of Strattera.

What is Hyperventilation?

Hyperventilation is found to be associated with 729 drugs and 1,442 conditions by eHealthMe. Check the latest studies of Hyperventilation.

On Apr, 22, 2026

27,428 people reported to have side effects when taking Strattera.
Among them, 44 people (0.16%) have Hyperventilation.

Among these 44 people:

How long have people been on Strattera when they have Hyperventilation? *

What is the gender of people who have Hyperventilation when taking Strattera? *

female: 47.62 %
male: 52.38 %

What is the age of people who have Hyperventilation when taking Strattera? *

What are other drugs people take besides Strattera? *

What are other side effects people have besides Hyperventilation? *

Dyspnea (difficult or laboured breathing): 13 people, 29.55%
Nausea And Vomiting: 11 people, 25.00%
High Blood Pressure: 8 people, 18.18%
Fatigue (feeling of tiredness): 8 people, 18.18%
Hyperhidrosis (abnormally increased sweating): 7 people, 15.91%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 7 people, 15.91%
Stress And Anxiety: 6 people, 13.64%
Panic Disorder: 6 people, 13.64%
Nausea (feeling of having an urge to vomit): 6 people, 13.64%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 5 people, 11.36%

What are the existing conditions these people have? *

Sleep Disorder: 2 people, 4.55%
Obsessive-Compulsive Disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;): 2 people, 4.55%
Bipolar Disorder (mood disorder): 2 people, 4.55%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 4.55%
Dermatitis Contact (skin reaction (dermatitis) resulting from exposure to allergens): 1 person, 2.27%
Affective Disorder (mental disorder): 1 person, 2.27%
Appetite Disorder (abnormal eating habits): 1 person, 2.27%
Birth Control: 1 person, 2.27%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 2.27%
Gilles De La Tourette Syndrome (a condition that causes people to make repeated, quick movements or sounds that they cannot control): 1 person, 2.27%

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and have Hyperventilation?

- Check whether Hyperventilation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Strattera:

Strattera (29,323 reports)

Browse all side effects of Strattera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperventilation:

Hyperventilation (729 drugs)

Browse all the conditions that are associated with Hyperventilation:

Hyperventilation (1,442 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on atomoxetine hydrochloride (the active ingredients of Strattera) and Strattera (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.